House Bill 4103 was passed by the Legislature, and approved by Governor Jim Justice, continuing the Office of Drug Control Policy within the Department of Health and Human Resource under the direction and supervision of the Secretary and with the assistance of the State Health Officer.
The Office is to develop recommendations to improve communication between health care providers and their patients about the risks and benefits of opioid therapy for acute pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose.
The Office shall develop a strategic plan to reduce the prevalence of drug and alcohol abuse and smoking, as well as make policy recommendations to executive branch agencies that work with alcohol and substance use disorder issues, and smoking cessation and prevention, to ensure the greatest efficiencies and consistency in practices will be applied to all efforts undertaken by the administration.
The Office is to also develop a program that provides assessment of persons who have been administered an opioid antagonist.
The Drug Control Policy shall develop and implement a program that requires the collection of data on the dispensing and use of an opioid antagonist from law enforcement agencies, emergency medical services, health care facilities, the Office of the Chief Medical Examiner and other entities are required by the office.
The Policy is to implement a program that requires the collection of data on the dispensing and use of an opioid antagonist form law enforcement agencies, emergency medical services, health care facilities, the Office of the Chief Medical Examiner and other entities as required by the Office.
